Pay in 4 interest-free payments of $7.46 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Some preliminary research suggests that GLP-1 receptor agonists might have anti-inflammatory properties and could potentially influence gut microbiome composition, but these findings remain investigational and have not translated into clinical practice or FDA-approved indications
Liraglutide is a GLP-1 receptor agonist compounded for weight-management support, available by prescription from a licensed provider
Cell Death
Comprehensive Metabolic Panel (80053) CPT code 80053 is used for the Comprehensive Metabolic Panel (CMP)
Nutritional support No nutrition coaching, meal plans, or dietary guidance available
Effectiveness and evidence The strongest, most reproducible evidence for weight loss comes from prescription injectable GLP-1 therapies like semaglutide and tirzepatide, with multiple large randomized trials showing significant weight reduction and metabolic benefits
US$ 22.90
US$ 29.69
US$ 24.00
US$ 21.76
US$ 24.78
US$ 23.77
US$ 21.63
US$ 21.57
